All questions are shown as received by the Trust.
“I would like to submit an FOI request for the number of vials used and patients treated for the following products at your trust used in 2024 (total January to December), broken down by brand and size, if possible. If the full-year data is not yet available, you can inform me about the currently available data.
If not all products are available at your institution, you can just fill in the data that you have access to.
Product
Prothrombin Complex Concentrate (PCC)
Beriplex CSL Behring 500IU 20ml
1000IU 40ml
Octaplex Octapharma 500IU 20ml
1000IU 40ml
Prothromplex Takeda 600IU 17ml
FEIBA Takeda 200IU 10ml
500IU 20ml
1000IU 40ml
Reversal Agents
Ondexxya (andexanet alfa) Astrazeneca 5x 200 mg
Praxbind (Idaracizumab) Boehringer Ingelheim 2x 2.5 g
Fibrinogen Concentrate (FC)
RiaSTAP CSL Behring 1.0g
FibCLOT LFB 1.5g
Fibryga Octapharma 1.0g
Fresh Frozen Plasma (FFP)
Fresh Frozen Plasma Blood banks
Octaplas Octapharma
Cryoprecipitate
Cryoprecipitate Blood banks
Labile Blood Products
Whole blood Blood banks
Red blood cells Blood banks
Platelets Blood banks
Factor XIII
Fibrogammin CSL Behring 250IU 4ml
1250IU 20ml

Fibrinogen Concentrate, Prothrombin Complex Concentrate, DOAC Antidote, and blood products.290125.docx